_gif.gif)
Superbrewed Food, Inc. has announced the commercial launch of Thryvia, a protein-derived postbiotic ingredient formulated to support digestive and immune health across functional food, beverage, dietary supplement, and pet nutrition applications.
The ingredient enters the market with established regulatory clearance, having received a "No Questions" letter from the US Food and Drug Administration (FDA) under Generally Recognised as Safe (GRAS) Notice GRN 1129.
Formulation Flexibility and Shelf Stability
Derived from heat-killed, non-viable Clostridium tyrobutyricum (strain ASM19), Thryvia is a room-temperature, shelf-stable postbiotic. Because the ingredient does not rely on maintaining live-organism viability throughout distribution and storage, it provides food and beverage manufacturers with processing flexibility compared to traditional live probiotics.
The ingredient is engineered for high-temperature and high-shear processing environments, including ultra-high temperature (UHT) liquid processing, extrusion, and baking.
Key technical specifications and formulation parameters include:
Inclusion Rate: Formulated for low inclusion levels, with a standard recommended dosage of approximately 200 mg per serving.
Matrix Compatibility: Suitable for capsules, dietary powders, gummies, nutritional bars, functional beverages, shelf-stable food systems, and animal nutrition.
Regulatory Clearance: Backed by an FDA GRAS "No Questions" letter (GRN 1129) for broad commercial deployment.
Bryan Tracy, Co-Founder and Chief Executive Officer of Superbrewed Food, stated that brand owners require differentiated ingredients backed by scientific research that maintain performance within commercial processing environments. Tracy noted that Thryvia bridges scientific validation with manufacturing parameters to offer brand partners a distinct formulation pathway.
Scientific Foundation and Receptor Activation
The launch is supported by an ongoing scientific research programme spanning mechanistic, preclinical, and human studies.
Third-party preclinical research demonstrates that Thryvia selectively activates pattern-recognition receptors TLR2, TLR5, and NOD2, which play a role in host immune response and gut barrier integrity. Controlled animal studies further demonstrate translational activity across intestinal pathways.
In a completed four-week consumer perception study, participants reported improvements across key measures of digestive comfort. Additional human clinical trials evaluating systemic digestive and immune outcomes remain underway.
Leadership Appointment
Alongside the commercial rollout, Superbrewed Food has appointed microbiome industry veteran Michael Bush as Co-Chairman of the Board.
Bush previously served as President and Chief Executive Officer of Ganeden, where he directed the commercialisation and international scaling of its branded probiotic platform prior to its acquisition by Kerry Group.
Michael Bush, Co-Chairman of Superbrewed Food, stated that Thryvia possesses the scientific backing and structural stability required to address unmet formulation needs across the food, beverage, supplement, and animal health sectors.
.jpg)
.jpeg)
